BOT 6.06% 35.0¢ botanix pharmaceuticals ltd

Sorry mate didn't intend to come across that way. Fair play. A...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 800 Posts.
    lightbulb Created with Sketch. 383
    Sorry mate didn't intend to come across that way. Fair play.

    A TO at current company progression isn't likely. We haven't completed phase 2. Pharma companies want it to be validated in a larger cohort. I would expect potential interest following phase 2. However, a biotech fund from the states is a preliminary sign of what (may) come our way.

    I was enjoying the 26c paper profits with my holdings but looks like this is gearing up for the next leg of development. Like all things in bio land/spec world, we can't expect this to continue in a linear line. Someone mentioned this has doubled in under a month. Extrapolate that though, and think what (could) happen to the MC following positive phase 2 results on 2 products, then anti-bacterial developments.

    TBH, as far as a CR goes I feel it has done well. However, 40M is a large dilution. No one can hide that.

    IHL got a placement, it sent rockets under the MC. But once again, came at a fraction of ours. So yeah, it's a tad disappointing but I think it goes without saying that this sort of interest is fantastic for the companies trajectory.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.